Genotoxic stress leads to centrosome amplification in breast cancer cell lines that have an inactive G1/S cell cycle checkpoint

Oncogene

Volumn 23, Issue 23, 2004, Pages 4068-4075

  D'Assoro, Antonino B ^a   Busby, Robert ^a   Suino, Kelly ^a   Delva, Emmanuella ^a   Almodovar Mercado, Gustavo J ^a   Johnson, Heidi ^a   Folk, Christopher ^a   Farrugia, Daniel J ^a   Vasile, Vlad ^a   Stivala, Franca ^a   Salisbury, Jeffrey L ^a  

^a Mayo Clinic   (United States)

Author keywords

Centrioles; Cyclin; Genomic instability; p53; Retinoblastoma

Indexed keywords

DAUNORUBICIN; HYDROXYUREA; PROTEIN P21; PROTEIN P53; ANTINEOPLASTIC AGENT; CYCLIN DEPENDENT KINASE;

ALLELE; ARTICLE; BIOACCUMULATION; BREAST CANCER; CANCER CELL; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CENTRIOLE; CENTROSOME; CHROMOSOME ABERRATION; CHROMOSOME DUPLICATION; CONTROLLED STUDY; DNA DAMAGE; DOWN REGULATION; GENE AMPLIFICATION; GENOTOXICITY; HUMAN; HUMAN CELL; MITOSIS INHIBITION; PHENOTYPE; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN FUNCTION; RETINOBLASTOMA; STRESS; BREAST TUMOR; CELL CULTURE; DRUG EFFECT; FEMALE; GENETICS; METABOLISM; PHYSIOLOGY;

MINK CELL FOCUS-FORMING VIRUS;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL CYCLE; CENTROSOME; CYCLIN-DEPENDENT KINASES; FEMALE; HUMANS; HYDROXYUREA; PHENOTYPE; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 2942619993     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207568     Document Type: Article

References (51)

1. Anbazhagan R, Gelber RD, Bettelheim R, Goldhirsch A and Gusterson BA. (1991). Ann. Oncol., 2, 47-53.
2. Angus SP, Fribourg AF, Markey MP, Williams SL, Horn HF, DeGregori J, Kowalik TF, Fukasawa K and Knudsen ES. (2002). Exp. Cell. Res., 276, 201-213.
3. Balczon R, Bao L, Zimmer WE, Brown K, Zinkowski RP and Brinkley BR. (1995). J. Cell. Biol., 130, 105-115.
4. Borel F, Lohez OD, Lacroix FB and Margolis RL. (2002). Proc. Natl. Acad. Sci. USA, 99, 9819-9824.
5. Brinkley BR. (2001). Trends Cell Biol., 11, 18-21.
6. D'Assoro AB, Barrett SL, Folk C, Negron VC, Boeneman K, Busby RC, Whitehead CM, Stivala F, Lingle LL and Salisbury JL. (2002a). Breast Cancer Res. Treat., 75, 25-34.
7. D'Assoro AB, Lingle WL and Salisbury JL. (2002b). Oncogene, 21, 6146-6153.
8. Duensing S and Munger K. (2002). Cancer Res., 62, 7075-7082.
9. Duensing S and Munger K. (2003). Crit. Rev. Eukaryot. Gene. Expr., 13, 9-23.
10. Faivre J, Frank-Vaillant M, Poulhe R, Mouly H, Jessus C, Brechot C and Sobczak-Thepot J. (2002). Oncogene, 21, 1493-1500.
11. Fry AM, Arnaud L and Nigg EA. (1999). J. Biol. Chem., 274, 16304-16310.
12. Fukasawa K, Choi T, Kuriyama R, Rulong S and Vande Woude GF. (1996). Science, 271, 1744-1747.
13. Gartel AL, Feliciano C and Tyner AL. (2003). Oncol. Res., 13, 405-408.
14. Goepfert TM, Adigun YE, Zhong L. Gay J, Medina D and Brinkley WR. (2002). Cancer Res., 62, 4115-4122.
15. Gunther T, Schneider-Stock R, Rys J, Niezabitowski A and Roessner A. (1997). J. Cancer Res. Clin. Oncol., 123, 388-394.
16. Hartwell LH and Weinert TA. (1989). Science, 246, 629-634.
17. Harvey M, Vogel H, Morris D, Bradley A, Bernstein A and Donehower LA. (1995). Nat. Genet., 9, 305-311.
18. Hinchcliffe EH, Li C, Thompson EA, Mailer JL and Sluder G. (1999). Science, 283, 851-854.
19. Jin S and Levine AJ. (2001). J. Cell Sci., 114, 4139-4140.
20. Kellogg DR. (1989). Nature, 340, 99-100.
21. Khong HT and Restifo NP. (2002). Nat. Immunol., 3, 999-1005.
22. Kirschner M and Mitchison T. (1986). Cell, 45, 329-342.
23. Kramer A, Neben K and Ho AD. (2002). Leukemia, 16, 767-775.
24. Kronenwett U, Castro J, Roblick UJ, Fujioka K, Ostring C, Faridmoghaddam F, Laytragoon-Lewin N, Tribukait B and Auer G. (2003). BMC Cell Biol., 4, 8.
25. Lacey KR, Jackson PK and Stearns T. (1999). Proc. Natl. Acad. Sci. USA, 96, 2817-2822.
26. Lane DP and Benchimol S. (1990). Genes Dev., 4, 1-8.
27. Lengauer C, Kinzler KW and Vogelstein B. (1998). Nature, 396, 643-649.
28. Levine AJ, Momand J and Finlay CA. (1991). Nature, 351, 453-456.
29. Lingle WL, Barrett SL, Negron VC, D'Assoro AB, Boeneman K, Liu W, Whitehead CM, Reynolds C and Salisbury JL. (2002). Proc. Natl. Acad. Sci. USA, 99, 1978-1983.
30. Lingle WL, Lutz WH, Ingle JN, Maihle NJ and Salisbury JL. (1998). Proc. Natl. Acad. Sci. USA, 95, 2950-2955.
31. Lingle WL and Salisbury JL. (1999). Am. J. Pathol., 155, 1941-1951.
32. Loeb LA. (2001). Cancer Res., 61, 3230-3239.
33. Meraldi P, Lukas J, Fry A, Bartek J and Nigg E. (1999). Nat. Cell Biol., 1, 88-93.
34. Mgbonyebi OP, Russo J and Russo IH. (1999). Cancer Res., 59, 1903-1910.
35. Murphy KL and Rosen JM. (2000). Oncogene, 19, 1045-1051.
36. Mussman JG, Horn HF, Carroll PE, Okuda M, Tarapore P, Donehower LA and Fukasawa K. (2000). Oncogene, 19, 1635-1646.
37. Okuda M. (2002). Oncogene, 21, 6170-6174.
38. Palazzo RE. (2003). Cell Motil. Cytoskeleton, 54, 148-154.
39. Pihan GA, Purohit A, Wallace J, Malhotra R, Liotta L and Doxsey SJ. (2001). Cancer Res., 61, 2212-2219.
40. Pihan GA, Wallace J, Zhou Y and Doxsey SJ. (2003). Cancer Res., 63, 1398-1404.
41. Pinto AE, Andre S, Mendonca E, Silva G and Soares J. (2003). Int. J. Biol. Markers, 18, 7-12.
42. Riley RR, Duensing S, Brake T, Munger K, Lambert PF and Arbeit JM. (2003). Cancer Res., 63, 4862-4871.
43. Rubin EH and William NH. (2003). Cancer Medicine 6, Bast RC, Kufe DW, Pollock RE, Weichselbaum RR, Holland JF, Frei E (eds). BC Decker Inc.: Hamilton Canada, pp 781-788.
44. Sakano K, Oikawa S, Hasegawa K and Kawanishi S. (2001). Jpn. J. Cancer Res., 92, 1166-1174.
45. Senderowicz AM. (2003). Oncogene, 22, 6609-6620.
46. Sluder G and Hinchcliffe EH. (2000). Centrosome in Cell Replication and Early Development, Vol. 49: Current Topics in Developmental Biology. Academic Press: San Diego, pp 267-289.
47. Tarapore P and Fukasawa K. (2002). Oncogene, 21, 6234-6240.
48. Tarapore P, Horn HF, Tokuyama Y and Fukasawa K. (2001). Oncogene, 20, 3173-3184.
49. Taylor WR and Stark GR. (2001). Oncogene, 20, 1803-1815.
50. Wang XW, Zhan Q, Coursen JD, Khan MA, Kontny HU, Yu L, Hollander MC, O'Connor PM, Fornace Jr AJ and Harris CC. (1999). Proc. Natl. Acad. Sci. USA, 96, 3706-3711.
51. Wenger CR, Beardslee S, Owens MA, Pounds G, Oldaker T, Vendely P, Pandian MR, Harrington D, Clark GM and McGuire WL. (1993). Breast Cancer Res. Treat., 28, 9-20.